Futura Medical plc

LSE FUM.L

Futura Medical plc Net Income for the year ending December 31, 2023: USD -8.29 M

Futura Medical plc Net Income is USD -8.29 M for the year ending December 31, 2023, a -17.28% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Futura Medical plc Net Income for the year ending December 31, 2022 was USD -7.07 M, a -5.32% change year over year.
Futura Medical plc Net Income for the year ending December 31, 2021 was USD -6.71 M, a -103.99% change year over year.
Futura Medical plc Net Income for the year ending December 31, 2020 was USD -3.29 M, a 72.17% change year over year.
Futura Medical plc Net Income for the year ending December 31, 2019 was USD -11.82 M, a -57.76% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

LSE: FUM.L

Futura Medical plc

CEO	Mr. James Henry Barder
IPO Date	July 22, 2003
Location	United Kingdom
Headquarters	Surrey Technology Centre
Employees	12
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Key trends

Past 5 years